Sou Hu Cai Jing·2025-07-20 19:11Group 1 - The stock price of Nocera Biopharma (688428) closed at 30.6 yuan on July 18, 2025, down 0.33% with a turnover rate of 2.88% and a trading volume of 77,200 shares, amounting to a total transaction value of 235 million yuan [1] - On July 18, 2025, the net outflow of main funds was 11.82 million yuan, accounting for 5.02% of the total transaction value, while retail investors saw a net inflow of 7.19 million yuan, representing 3.06% of the total transaction value [2][4] - Nocera Biopharma submitted a disclosure report on July 18, 2025, indicating that the number of issued shares and treasury shares remained unchanged at 1,494,598,235 shares and 1,686,000 shares, respectively, totaling 1,496,284,235 shares [2] Group 2 - On July 18, 2025, Nocera Biopharma issued a total of 2,076,750 new RMB shares under the 2023 RMB Share Incentive Plan, with an issuance price of 6.95 yuan per share [3][4] - The issuance included 512,500 shares to 2 directors, 1,169,750 shares to 94 incentive recipients, and 394,500 shares to 42 incentive recipients, resulting in an increase in the total number of issued RMB shares from 266,282,967 to 268,359,717 shares [3]